Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Douglas Hunt
Age : 55
Public asset : 460,263 USD
Linked companies : Puma Biotechnology, Inc.
Summary 
Currently, Douglas Hunt holds the position of SVP-Regulatory Affairs & Medical Writing at Puma Biotechnology, Inc.

He previously occupied the position of Executive Director-Therapeutic Area at Amgen, Inc., Vice President-Global Regulatory Affairs at Baxter Healthcare Corp. and VP-Regulatory Affairs & Quality Assurance at ArmaGen, Inc.

Mr. Hunt received an undergraduate degree from the University of Portsmouth.


Current positions of Douglas Hunt 
NameTitle Since
Puma Biotechnology, Inc.
(Biotechnology & Medical Research)
SVP-Regulatory Affairs & Medical Writing 2018


Holdings of Douglas Hunt 
NameEquities%Valuation
Puma Biotechnology, Inc. (PBYI)
(Biotechnology & Medical Research)
65,6580.16%460,263 USD


Douglas Hunt: Personal Network 
Most Read News 
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
RE
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
RE
10/11JAMIE DIMON : JPMorgan's Dimon blasts bitcoin as 'worthless', due for regulation
RE
10/20JACK MA : Alibaba founder Ma spotted in Mallorca in rare trip abroad after China scrutiny
RE
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
RE
10/21ALEXANDRE RICARD : Pernod Ricard 1Q Sales Soar as Drinkers Head to the Bars
DJ
10/22WARREN BUFFETT : Generali closer to controlling Cattolica after Buffett tenders shares - source
RE
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
RE
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
RE
10/20ELON MUSK : No Elon Musk Show during this Tesla quarterly call
RE
More news


© 2021 People and Ownership :   
Douglas Hunt : Connections